Overview
Interactions between the regulatory regime and intellectual property (for example, SPC, data exclusivity), product liability (e.g., off-label information in summary of product characteristics (SmPC), competition (for example, public procurement) and privacy (e.g., clinical trials) rules are increasing. As a result, those matters can no longer be approached in isolation, and a more comprehensive perspective is required when addressing regulatory issues.
Have an account?